Mild irritation: redness, dryness, or itching at the application site
Semaglutide 0.25mg, 0.5mg, 1mg Injection GLP-1 Receptor Agonist for Type 2 Diabetes Ozempic (Semaglutide) Once-Weekly GLP-1 Receptor Agonist for Type 2 Diabetes Gold Standard GLP-1 Therapy for Blood Sugar Control and Cardiovascular Risk Reduction Ozempic (Semaglutide) is a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist used to improve blood sugar control in adults with Type 2 diabetes
When combined with appetite suppressants like Ozempic, patients often cannot distinguish which medication causes which side effect, leading to confusion about safety and efficacy
GLP-1 Nutritional Risk Stratification Framework This framework summarises when nutritional monitoring or intervention may be appropriate during GLP-1 therapy
When given by a trained professional, B12 injections are widely considered safe and well-tolerated
The researchers also found reduced responsiveness to GLP-1 in both the pancreas and the gut of these mice
